Clinical characteristics and management of Gorham’s disease:a pooled analysis of 210 cases
Feng LIAO,Wei-feng LIU,Xiao-hui NIU
DOI: https://doi.org/10.3969/j.issn.2095-252X.2016.09.007
2016-01-01
Abstract:Objective Gorham’s disease ( GD ) is a rare disorder characterized by spontaneous resorption of bones. This study aims to analyze the patients’ clinical characteristics, the value of different treatment modalities and their inlfuences on the clinical outcomes. Methods A literature search in PubMed, ScienceDirect, ProQuest and Springer Link were performed, and all clinical reports about GD published before April 2016 were included. Gender, age, site of lesion, symptom, sign, complication, image characteristics, pathological features, management, follow-up time and results of every patient were extracted. Results A total of 210 cases of GD in 151 papers were enrolled for analysis. The male-to female ratio of this disease was 1.84:1, and mean age of diagnosis was 21 years ( from 2 months to 83 years ). Although GD could affect any bone in the body, it frequently affected the maxilla, clavicle, ribs, thoracic vertebrae, pelvis and femur. Areas of bone resorption could arise in a single bone ( 30%cases ) or in multiple contiguous bones ( 70% cases ). Patients with GD might initially presented with insidious onset of localized pain ( 80%cases ), dyspnea, fracture, or functional impairment. Plain X-rays and computed tomography, initially, showed radiolucent foci in the intramedullary or subcortical regions and, later, slowly progressive disappearance of a part of a bone. In sections of the affected bone, numerous dilated thin-walled endothelial-lined vessels could be observed in ifbrous tissues. The mechanism of bone resorption had not been clariifed, but many studies implied GD was a metabolic disease, caused by hyperactivity of osteoclasts. Radiotherapy, bisphosphonates and interferon alpha 2b were widely used to prevent resorption of the bone. About 70 patients underwent radiotherapy, among them, follow-up data of 32 patients were available:24 cases had the disorder locally controlled, 3 had a symptom progression and 5 died in four years. More than 30 patients received treatment with bisphosphonates, follow-up data of 16 patients were available:9 cases had the disorder locally controlled in two years, 4 had a symptom progression and the other 3 died in four years. More than 20 patients received treatment of interferon alpha 2b, 8 cases of them had the disorder locally controlled in two years, 2 had a symptom progression in one year and the other 2 died in four years.The mortality of GD was 13%, and prognosis was worse if the patient present with neurological complications or chylothorax. Conclusions GD has no speciifc symptoms and it should be taken into consideration when an unclear massive osteolysis occurs. The diagnosis of GD is mainly based on the imaging and pathological examination. The efifcacies of different treatment modalities are still unpredictable and further research is required to assess the value of those treatments.